155 related articles for article (PubMed ID: 26337470)
1. Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients.
Solini A; Simeon V; Derosa L; Orlandi P; Rossi C; Fontana A; Galli L; Di Desidero T; Fioravanti A; Lucchesi S; Coltelli L; Ginocchi L; Allegrini G; Danesi R; Falcone A; Bocci G
Oncotarget; 2015 Oct; 6(30):28743-54. PubMed ID: 26337470
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab.
Allegrini G; Coltelli L; Orlandi P; Fontana A; Camerini A; Ferro A; Cazzaniga M; Casadei V; Lucchesi S; Bona E; Di Lieto M; Pazzagli I; Villa F; Amoroso D; Scalese M; Arrighi G; Molinaro S; Fioravanti A; Finale C; Triolo R; Di Desidero T; Donati S; Marcucci L; Goletti O; Del Re M; Salvadori B; Ferrarini I; Danesi R; Falcone A; Bocci G
Pharmacogenomics; 2014 Dec; 15(16):1985-99. PubMed ID: 25521357
[TBL] [Abstract][Full Text] [Related]
3. Genetic interaction analysis of VEGF-A rs3025039 and VEGFR-2 rs2071559 identifies a genetic profile at higher risk to develop nodular goiter.
Molinaro A; Orlandi P; Niccolai F; Agretti P; De Marco G; Ferrarini E; Di Cosmo C; Vitti P; Piaggi P; Di Desidero T; Bocci G; Tonacchera M
J Endocrinol Invest; 2020 Feb; 43(2):149-155. PubMed ID: 31376092
[TBL] [Abstract][Full Text] [Related]
4. Genetic interaction of purinergic P2X7 receptor and ER-α polymorphisms in susceptibility to osteoporosis in Chinese postmenopausal women.
Wang H; Gong C; Liu X; Rao S; Li T; He L; Nie Y; Wang S; Zhong P; Xue Y; Wang J; Zhao J; Zhou Y; Ding L; Tu Y; Yang Y; Xiong C; Liang S; Xu H
J Bone Miner Metab; 2018 Jul; 36(4):488-497. PubMed ID: 28884379
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor receptor 2 gene polymorphisms as predictors for tumor recurrence and overall survival in non-small-cell lung cancer.
Uzunoglu FG; Kaufmann C; Wikman H; Güngör C; Bohn BA; Nentwich MF; Reeh M; Pantel K; Bockhorn M; Kutup A; Mann O; Izbicki JR; Vashist YK
Ann Surg Oncol; 2012 Jul; 19(7):2159-68. PubMed ID: 22395975
[TBL] [Abstract][Full Text] [Related]
6. Association of rs6983561 polymorphism at 8q24 with prostate cancer mortality in a Japanese population.
Suzuki M; Liu M; Kurosaki T; Suzuki M; Arai T; Sawabe M; Kasuya Y; Kato M; Fujimura T; Fukuhara H; Enomoto Y; Nishimatsu H; Ishikawa A; Kume H; Homma Y; Kitamura T
Clin Genitourin Cancer; 2011 Sep; 9(1):46-52. PubMed ID: 21700508
[TBL] [Abstract][Full Text] [Related]
7. A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies.
Chua MLK; Lo W; Pintilie M; Murgic J; Lalonde E; Bhandari V; Mahamud O; Gopalan A; Kweldam CF; van Leenders GJLH; Verhoef EI; Hoogland AM; Livingstone J; Berlin A; Dal Pra A; Meng A; Zhang J; Orain M; Picard V; Hovington H; Bergeron A; Lacombe L; Fradet Y; Têtu B; Reuter VE; Fleshner N; Fraser M; Boutros PC; van der Kwast TH; Bristow RG
Eur Urol; 2017 Nov; 72(5):665-674. PubMed ID: 28511883
[TBL] [Abstract][Full Text] [Related]
8. Purinergic P2X7 receptor functional genetic polymorphisms are associated with the susceptibility to obesity in Chinese postmenopausal women.
Liu X; Rao S; Gong C; Li T; Ding L; Wang S; Zhong P; Wang J; Zhao J; Zhou Y; Xiong C; Tu Y; Liang S; Xu H
Menopause; 2018 Mar; 25(3):329-335. PubMed ID: 29088017
[TBL] [Abstract][Full Text] [Related]
9. The rs2071559 AA VEGFR-2 genotype frequency is significantly lower in neovascular age-related macular degeneration patients.
Lazzeri S; Orlandi P; Figus M; Fioravanti A; Cascio E; Di Desidero T; Agosta E; Canu B; Sartini MS; Danesi R; Nardi M; Bocci G
ScientificWorldJournal; 2012; 2012():420190. PubMed ID: 22919317
[TBL] [Abstract][Full Text] [Related]
10. Genotype Correlations With Blood Pressure and Efficacy From a Randomized Phase III Trial of Second-Line Axitinib Versus Sorafenib in Metastatic Renal Cell Carcinoma.
Escudier B; Rini BI; Motzer RJ; Tarazi J; Kim S; Huang X; Rosbrook B; English PA; Loomis AK; Williams JA
Clin Genitourin Cancer; 2015 Aug; 13(4):328-337.e3. PubMed ID: 25816720
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancer.
Sunakawa Y; Cao S; Berger MD; Matsusaka S; Yang D; Zhang W; Ning Y; Parekh A; Stremitzer S; Mendez A; Okazaki S; Wakatsuki T; Azuma M; Shimada K; Watanabe M; Koizumi W; Wu AH; Lenz HJ
Pharmacogenomics J; 2017 Jan; 17(1):36-41. PubMed ID: 26503819
[TBL] [Abstract][Full Text] [Related]
12. VEGFR-2, CXCR-2 and PAR-1 germline polymorphisms as predictors of survival in pancreatic carcinoma.
Uzunoglu FG; Kolbe J; Wikman H; Güngör C; Bohn BA; Nentwich MF; Reeh M; König AM; Bockhorn M; Kutup A; Mann O; Izbicki JR; Vashist YK
Ann Oncol; 2013 May; 24(5):1282-90. PubMed ID: 23293110
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes.
Marks ECA; Wilkinson TM; Frampton CM; Skelton L; Pilbrow AP; Yandle TG; Pemberton CJ; Doughty RN; Whalley GA; Ellis CJ; Troughton RW; Owen MC; Pattinson NR; Cameron VA; Richards AM; Gieseg SP; Palmer BR
BMC Cardiovasc Disord; 2018 Aug; 18(1):169. PubMed ID: 30111293
[TBL] [Abstract][Full Text] [Related]
14. Association between NLPR1, NLPR3, and P2X7R Gene Polymorphisms with Partial Seizures.
Wang H; Xu P; Liao D; Dang R; He X; Guo Y; Jiang P
Biomed Res Int; 2017; 2017():9547902. PubMed ID: 28503575
[No Abstract] [Full Text] [Related]
15. Possible protective role of the 489C>T P2X7R polymorphism in Alzheimer's disease.
Sanz JM; Falzoni S; Rizzo R; Cipollone F; Zuliani G; Di Virgilio F
Exp Gerontol; 2014 Dec; 60():117-9. PubMed ID: 25456845
[TBL] [Abstract][Full Text] [Related]
16. Germline Polymorphisms of the VEGF Pathway Predict Recurrence in Nonadvanced Differentiated Thyroid Cancer.
Marotta V; Sciammarella C; Capasso M; Testori A; Pivonello C; Chiofalo MG; Gambardella C; Grasso M; Antonino A; Annunziata A; Macchia PE; Pivonello R; Santini L; Botti G; Losito S; Pezzullo L; Colao A; Faggiano A
J Clin Endocrinol Metab; 2017 Feb; 102(2):661-671. PubMed ID: 27849428
[TBL] [Abstract][Full Text] [Related]
17. Genetic variations in TP53 binding sites are predictors of clinical outcomes in prostate cancer patients.
Lin VC; Huang CY; Lee YC; Yu CC; Chang TY; Lu TL; Huang SP; Bao BY
Arch Toxicol; 2014 Apr; 88(4):901-11. PubMed ID: 24448834
[TBL] [Abstract][Full Text] [Related]
18. The VEGFR-2 protein and the VEGFR-2 rs1870377 A>T genetic polymorphism are prognostic factors for gastric cancer.
Zhu X; Wang Y; Xue W; Wang R; Wang L; Zhu ML; Zheng L
Cancer Biol Ther; 2019; 20(4):497-504. PubMed ID: 30380970
[TBL] [Abstract][Full Text] [Related]
19. Two Single Nucleotide Polymorphisms in the Purinergic Receptor
Guerini FR; Agliardi C; Bolognesi E; Zanzottera M; Caputo D; Pasanisi MB; Rovaris M; Clerici M
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499708
[TBL] [Abstract][Full Text] [Related]
20. Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer.
Evans JR; Zhao SG; Chang SL; Tomlins SA; Erho N; Sboner A; Schiewer MJ; Spratt DE; Kothari V; Klein EA; Den RB; Dicker AP; Karnes RJ; Yu X; Nguyen PL; Rubin MA; de Bono J; Knudsen KE; Davicioni E; Feng FY
JAMA Oncol; 2016 Apr; 2(4):471-80. PubMed ID: 26746117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
